| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |